No Data
No Data
American Health (002044): Strong rise in volume and price, leading performance growth, development prospects can be expected
Performance Brief Review On April 24, 2024, the company released its 2023 annual report. In 2023, the company achieved revenue of 10.89 billion yuan (+26.4%, year-on-year, same below); realized net profit of 5.06 billion yuan to mother
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to p
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to promote performance growth; 2) digital operation enables development, and the layout of AI continues to innovate. (Mainichi Keizai Shimbun)
Nugget AI just when American Health's 2023 revenue exceeded 10.8 billion yuan
On the evening of April 24, Meinian Health Industry Holdings Co., Ltd. (hereinafter referred to as “American Health”, 002044.SZ) released its 2023 annual report showing that the company achieved operating income of 10.894 billion yuan, an increase of 26.44%; net profit to the mother of 506 million yuan, an increase of 1,065 million yuan over the same period of the previous year; total number of visitors increased 13.0% year on year, comprehensive customer unit price increased 11.2% year on year, and achieved strong growth in the first year of post-epidemic recovery. The company said that in 2024, it will adhere to a firm quality and efficiency orientation and adhere to “sustainable growth driven by digital intelligence, diversified growth and high quality profits
American Health (002044.SZ) announced its 2023 annual results, with net profit of 506 million yuan, turning a loss into a profit
According to Zhitong Finance App News, American Health (002044.SZ) released its 2023 annual report. The company's operating income was 10.894 billion yuan, an increase of 26.44% over the previous year; net profit attributable to shareholders of listed companies was 506 million yuan, which turned a loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 463 million yuan, which turned a loss into a profit; basic earnings per share were 0.13 yuan/share. It is proposed to distribute a cash dividend of 0.19 yuan (tax included) for every 10 shares to all shareholders.
Express News | American Health: Net profit due to mother in 2023 was 506 million yuan, an increase of 190.45% year-on-year
American Health's “All in AI” enters the golden track of “AI+ Healthcare”
Health management robots are here, and the big domestic healthcare AI model has welcomed new samples. According to reports, on April 15 of this year, Meinian Health's new AI application product, the “Health Xiaomei” digital intelligence manager, began internal trial operation. According to official sources, this is the first AI robot for health management in China. Through this product, users can generate a health management plan adapted to their own with one click after uploading information such as personal lifestyle habits and exercise conditions; they can also obtain exclusive medical examinations and prevention plans based on personal health data, lifestyle habits, family medical history, etc. Simply put, using “Healthy and Little Beauty” is equivalent to having a 24-hour person
No Data